FDA approves first at-home cervical cancer screening device
HPV vaccination and regular screening are highly effective at preventing the disease.
HPV vaccination and regular screening are highly effective at preventing the disease.

A number of the victims were found near a fire exit that authorities believe may have been blocked.

Iran’s Revolutionary Guards said they had struck US military targets and bases in Jordan, Bahrain and Kuwait.

Qatar's government on Sunday announced the death of former leader Sheikh Hamad bin Khalifa Al Thani, who led the…

WASHINGTON, United States (AFP) — US President Donald Trump faced questions about the security of his new Air Force One…

QUITO, Ecuador (AFP) — When Diana Tupiza and Andres Alquinga decided to get married, they selected a rather unusual…

The 'Teal Wand' -- a self-collection vaginal swab shaped like a tampon and developed by Teal Health -- will be available online for individuals aged 25 to 65 who are at average risk for cervical cancer
Nicole Morrison/Teal Health/AFP
What's your take?
Google Preferred Sources
Get more Daily Tribune stories in your search results
Add Daily Tribune as a preferred source on Google Search.
Continue reading
WASHINGTON, United States (AFP) — The US Food and Drug Administration has approved an at-home cervical cancer screening tool as an alternative to Pap smears by a gynecologist, the company behind the device said Friday.
The “Teal Wand” — a self-collection vaginal swab shaped like a tampon and developed by Teal Health — will be available online for individuals aged 25 to 65 who are at average risk for cervical cancer.
Users request a kit online, have a brief visit with a telehealth provider to gauge eligibility and then the kit is prescribed. They then collect the sample and ship it to a lab for analysis.
Cervical cancer, which affects the lower part of the uterus, is diagnosed in about 0.6 percent of women. Although human papillomavirus (HPV) vaccination and regular screening are highly effective at preventing the disease, more than one in four women fall behind on routine appointments.
“When we make care easier to get, we help women stay healthy, for themselves and for the people who rely on them every day,” Teal Health CEO Kara Egan said in a statement.
The Teal Wand tests for high-risk strains of HPV, the primary cause of cervical cancer.
A large clinical trial found its accuracy comparable to a traditional Pap smear, which requires a speculum and is often cited as a barrier to screening due to discomfort.
Most sexually active people will contract HPV at some point, though only a small fraction develop cancer.
Teal Health did not disclose pricing but said it is in talks with insurers to ensure affordability. The product will launch first in California in June.